We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-35.84%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
10 Year Est. Return
AUM
$105M
AUM Growth
-$80.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DICE
1
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$51.1M 48.67%
3,292,871
ISO
2
DELISTED
IsoPlexis Corporation Common Stock
ISO
$19M 18.12%
8,808,531
TBIO
3
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$17.7M 16.88%
546,896
VIGL
4
DELISTED
Vigil Neuroscience
VIGL
$10.9M 10.36%
4,214,498
CADL icon
5
Candel Therapeutics
CADL
$689M
$6.27M 5.97%
1,935,215

Similar funds

Northpond Ventures's Q2 2022 Portfolio in Review

As of Q2 2022, Northpond Ventures held 5 positions worth $105M, down 43% from $186M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Northpond Ventures opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures's ten largest holdings make up 100% of its $105M portfolio in Q2 2022.
  • Northpond Ventures opened 0 new positions and closed 0 in Q2 2022.
  • Northpond Ventures's portfolio value fell 43% quarter-over-quarter to $105M.

Based on Northpond Ventures's 13F filing for Q2 2022, filed 1 Aug 2022.